Rodents exposed to phone radiation actually lived longer than unexposed animals, reviewers point out
Scientists measured evidence of exposure in the womb and found an association, but not proof
Mosquito repellents are safe, so you should use them. And there are more choices than ever. WebMD breaks down your options.
Researchers find the virus can replicate in immune cells
Pennsylvania case suggests it's almost 'the end of the road' for these drugs
BEIJING (AP) — China's decision to allow all married couples to have two children is driving a surge in demand for fertility treatment among older women, putting heavy pressure on clinics and breaking down past sensitivities, and even shame, about the issue.
At Human Longevity Inc. (HLI), our goal is to extend the healthy human lifespan and to revolutionize healthcare.You've often heard me speak about how converging exponential technologies have the potential to disrupt industries. This is a blog providing a detailed overview of the road map for reinventing medicine and extending your "healthy,...
By Bill Berkrot NEW YORK (Reuters) - Drugmakers are renewing efforts to develop medicines to fight emerging antibiotic-resistant bacteria, but creating new classes of drugs on the scale needed is unlikely to happen without new financial incentives to make the effort worth the investment, companies and industry experts said. "The return on investment based on the current commercial model is not really commensurate with the amount of effort you have to put into it," said David Payne, who heads GlaxoSmithKline PLC's antibiotics drug group. Other pharmaceutical companies expressed a similar sentiment.